Skip to main content
Log in

Chronic fatigue: A peculiar evolution of Eosinophilia Myalgia Syndrome following treatment withl-tryptophan in four Italian adolescents

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

We describe four Italian adolescents in whom a persistent, debilitating fatigue appeared after therapeutic ingestion of products containingl-tryptophan and subsequent to the development of a transient rise in eosinophil count and severe myalgia (Eosinophilia Myalgia Syndrome-EMS). Their clinical picture was indistinguishable from that of the socalled Chronic Fatigue Syndrome. A chronic fatigue may occur after diverse triggering agents and it represents the peculiar clinical evolution of these four paediatric cases of EMS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CFS :

Chronic Fatigue Syndrome

EMS :

Eosinophilia Myalgia Syndrome

ANA :

antinuclear antibodies

References

  1. Bakheit AMO, Behan PO, Dinan TG, Gray CE, O'Keane V (1992) Possible upregulation of hypothalamic 5 hydroxytryptamine receptors in patients with post viral fatigue syndrome. BMJ 304:1010–1012

    PubMed  Google Scholar 

  2. Bell KM, Cookfire D, Bell DS, Reese P, Cooper I (1991) Risk factor associated with chronic fatigue syndrome in a cluster of pediatric cases. Rev Infect Dis 13 [Suppl 1]:S32/8

    Google Scholar 

  3. Centers for Disease Control (1989) Eosinophilia-myalgia syndrome: New Mexico. MMWR 38:765–767

    Google Scholar 

  4. Culpepper RC, Williams RG, Mease PJ, Kalpsell TD, Kobayashi JM (1991) Natural history of the EMS. Ann Intern Med 115:437–442

    PubMed  Google Scholar 

  5. Holmes GP, Kaplan JE, Gantz NM, Komaroff Al, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, Tosato G, Zegans LS, Purtilo DT, Brown N, Scholey RT, Brus I (1989) CFS: a working case definition. Ann Intern Med 108:387–389

    Google Scholar 

  6. Mayeno AN, Lin F, Foote CS, Loegering DA, Ames MM, Hedberg CW (1990) Characterization of “Peak E”, a novel amino acid associated with eosinophilia-myalgia syndrome. Science 250:1707–1708

    PubMed  Google Scholar 

  7. Press RI, Peebles CL, Kumagai Y, Ochs RL, Tan EM (1992) Antinuclear antibodies in women with silicone breast implants. Lancet 340:1304–1307

    PubMed  Google Scholar 

  8. Rikard-Bell CJ, Waters BGH (1992) Psychosocial management of chronic fatigue syndrome in adolescence. Aust NZ J Psychiatry 26:64–72

    Google Scholar 

  9. Varga J, Vitto J, Jimenez SA (1992) The cause and pathogenesis of Eosinophilia-Myalgia-Syndrome. Ann Intern Med 116:140–147

    PubMed  Google Scholar 

  10. Varga J, Jimenez SA, Uitto J (1993) L-Tryptophan and the eosinophilia-myalgia syndrome: current understanding of the ethiology and pathogenesis. J Invest Dermatol 100:97S-105S

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Priori, R., Conti, F., Luan, F.L. et al. Chronic fatigue: A peculiar evolution of Eosinophilia Myalgia Syndrome following treatment withl-tryptophan in four Italian adolescents. Eur J Pediatr 153, 344–346 (1994). https://doi.org/10.1007/BF01956416

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01956416

Key words

Navigation